Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-20 6:05 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 58,651,170 15.3% | 29,544,805 (+101.51%) | View |
| 2024-03-01 4:18 pm Sale | 13G | API GROUP CORP COM APG | VIKING GLOBAL INVESTORS LP | 32,022,915 12.3% | -10,494,242 (-24.68%) | View |
| 2024-02-28 4:28 pm Sale | 13G | RAYZEBIO INC RYZB | VIKING GLOBAL INVESTORS LP | 0 0% | -6,642,700 (Position Closed) | View |
| 2024-02-14 10:27 am Purchase | 13G | PHARVARIS N V REGISTERED PHVS | VIKING GLOBAL INVESTORS LP | 3,656,923 7% | 425,000 (+13.15%) | View |
| 2024-02-14 10:26 am Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | VIKING GLOBAL INVESTORS LP | 6,159,146 9.7% | 1,750,000 (+39.69%) | View |
| 2024-02-14 10:25 am Purchase | 13G | API GROUP CORP COM APG | VIKING GLOBAL INVESTORS LP | 42,517,157 17.4% | 421,364 (+1.00%) | View |
| 2024-02-14 10:24 am Sale | 13G | AMYLYX PHARMACEUTICALS INC AMLX | VIKING GLOBAL INVESTORS LP | 2,962,555 4.4% | -1,672,051 (-36.08%) | View |
| 2024-02-14 10:23 am Unchanged | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 20.7% | 0 (Unchanged) | View |
| 2024-02-14 10:21 am Purchase | 13G | TREVI THERAPEUTICS INC TRVI | VIKING GLOBAL INVESTORS LP | 6,599,062 9.99% | 436,700 (+7.09%) | View |
| 2024-02-14 10:20 am Sale | 13G | ROIVANT SCIENCES LTD SHS ROIV | VIKING GLOBAL INVESTORS LP | 69,368,961 8.6% | -5,869,739 (-7.80%) | View |
| 2024-02-14 10:18 am Unchanged | 13G | RALLYBIO CORP COM RLYB | VIKING GLOBAL INVESTORS LP | 4,194,777 11.1% | 0 (Unchanged) | View |
| 2024-02-14 10:17 am Sale | 13G | PEPGEN INC PEPG | VIKING GLOBAL INVESTORS LP | 1,482,434 6.2% | -62,197 (-4.03%) | View |
| 2024-02-14 10:16 am Unchanged | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | VIKING GLOBAL INVESTORS LP | 143,085,126 8.8% | 0 (Unchanged) | View |
| 2024-02-14 10:15 am Sale | 13G | VALVOLINE INC VVV | VIKING GLOBAL INVESTORS LP | 3,176,309 2.4% | -5,162,147 (-61.91%) | View |
| 2024-02-14 10:13 am Sale | 13G | VIKING THERAPEUTICS INC VKTX | VIKING GLOBAL INVESTORS LP | 5,145,112 5.1% | -713,420 (-12.18%) | View |
| 2024-02-14 10:12 am Purchase | 13G | NEWAMSTERDAM PHARMA CO NV SHS NAMS | VIKING GLOBAL INVESTORS LP | 8,024,565 9.7% | 1,500,000 (+22.99%) | View |
| 2024-02-14 10:11 am Sale | 13G | FIVE9 INC FIVN | VIKING GLOBAL INVESTORS LP | 2,714,117 3.7% | -933,478 (-25.59%) | View |
| 2024-02-14 10:00 am Purchase | 13G | VERASTEM INC VSTM | VIKING GLOBAL INVESTORS LP | 2,531,829 9.99% | 1,211,173 (+91.71%) | View |
| 2024-02-14 10:00 am Purchase | 13G | INHIBRX INC INBX | VIKING GLOBAL INVESTORS LP | 7,150,826 15.1% | 511,627 (+7.71%) | View |
| 2024-02-05 4:29 pm Unchanged | 13D | CAZOO GROUP LTD OCT 2023 CZOO | VIKING GLOBAL INVESTORS LP | 2,142,728 43.8% | 0 (Unchanged) | View |